Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_assertion type Assertion NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_head.
- NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_assertion description "[During the 18-month follow-up period after the start of tuberculosis treatment, 6/18 (33%) cases with Hp 2-2 phenotype died compared to 9/47 (19%) with Hp 2-1 and 3/31 (10%) with Hp 1-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_provenance.
- NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_assertion evidence source_evidence_literature NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_provenance.
- NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_assertion SIO_000772 10949330 NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_provenance.
- NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_assertion wasDerivedFrom befree-20150227 NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_provenance.
- NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_assertion wasGeneratedBy ECO_0000203 NP983688.RAcwfK607c4idfbMwxz6-CUaPWQIRDjPfH-SL5j-hriXY130_provenance.